fenofibrate
fenofibrate: sourced relationships with 1 company · 2 clinical trials tracked · 1 FDA decision.
fenofibrate evidence translation
What we can confirm
1 FDA record · 2 tracked trials
What it means
What to watch
Prepared research question
How could fenofibrate → ANIP affect its developer, and what evidence supports the link?
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Dated Pipeline Records (1)
| Company | Dated record stage |
|---|---|
| ANI PHARMACEUTICALS INC (ANIP) Reported 2018-04-30 · Current development: unknownSource | Approved |
Clinical Trial Registry Records (2)
Phase 2a Study of the Effect of Serine Supplementation and Fenofibrate Treatment on Serum Deoxysphinganine Levels in Patients With Macular Telangiectasia (MacTel) Type 2 (SAFE Study)
Primary endpoint: Safety Assessment
A Randomized Clinical Trial Evaluating Fenofibrate for Prevention of Diabetic Retinopathy Worsening
Primary endpoint: Worsening of diabetic retinopathy
Frequently asked questions
Which companies have sourced relationships with fenofibrate?
fenofibrate has dated SEC/FDA relationship records for ANI PHARMACEUTICALS INC.
How many clinical trials involve fenofibrate?
BioSniper tracks 2 clinical trials involving fenofibrate.
What is fenofibrate's latest FDA decision?
The most recent tracked FDA decision for fenofibrate is Approval, dated April 30, 2018.